AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimilife-M3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Lakshya Pharma Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimilife-M3 Tablet SR

DiaGlyce-Duo SR tablets are classified as antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. This medication helps regulate blood glucose. DiaGlyce-Duo SR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications including nephropathy, retinopathy, neuropathy, and limb loss. DiaGlyce-Duo SR is one component of a comprehensive diabetes management plan, incorporating a doctor-recommended diet, exercise, and weight management. Lifestyle factors significantly influence diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be recommended by your doctor.

Uses of Glimilife-M3 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimilife-M3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimilife-M3 Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this medication with a meal.

Common Side effects of Glimilife-M3 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilife-M3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimilife-M3 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication should be taken with food.

How Glimilife-M3 Tablet SR works:

Glimilife-M3 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glimilife-M3 Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimilife-M3 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Glimilife-M3 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimilife-M3 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimilife-M3 SR tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilife-M3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glimilife-M3 Tablet SR is typically initiated at a reduced dose; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimilife-M3 Tablet SR :

Should you forget to take a Glimilife-M3 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimilife-M3 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimilife-M3 Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimilife-M3 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glimilife-M3 Tablet SR and seek immediate medical attention.
Glimilife-M3 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for treating type 1 DM.
Glimilife-M3 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimilife-M3 Tablet SR use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Glimilife-M3 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimilife-M3 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Glimilife-M3 Tablet SR
148
MRP 181
18% off